Navigation Links
HIV-derived antibacterial shows promise against drug-resistant bacteria
Date:6/19/2013

A team of researchers at the University of Pittsburgh has developed antibacterial compounds, derived from the outer coating of HIV, that could be potential treatments for drug-resistant bacterial infections and appear to avoid generating resistance. These new agents are quite small, making them inexpensive and easy to manufacture. The research was published in the June 2013 issue of the journal Antimicrobial Agents and Chemotherapy.

The first of many probable applications will likely be the chronic bacterial infections in the lungs of cystic fibrosis patients "that frequently develop resistance to all standard antibiotics, and are the leading cause of death in these patients," says senior author Ronald Montelaro.

The lead compound shows powerful antibacterial activity against clinical isolates of diverse pathogenic bacteria that are resistant to most antibiotics. These agents, called engineered cationic antimicrobial peptides (eCAPs) "may be applicable to treatment of other respiratory infections, topical infections, and systemic infections," says Montelaro.

The genesis of the new agent was basic research on HIV envelope protein structure and function, says Montelaro. As part of this research, "we identified highly conserved unique protein sequences that were predicted by computer modeling to assume structures characteristic of natural antibacterial peptides. Since antibacterial peptides specifically target and disrupt the integrity and function of bacterial membranes, we thought that these similar peptide sequences in the HIV envelope protein might contribute to toxicity and death in infected cells by altering cell membranes."

The team engineered the original HIV peptides for greater effectiveness and smaller size, the latter to reduce manufacturing expenses. The engineering involved modifying amino acid content (they contain just two different amino acids), peptide length, charge, and hydrophobicity. The current paper describes the third generation peptides. The lead agent contains just 12 amino acid residues.

"Another potential application is biodefense, where eCAPs may be used as a rapid postexposure aerosol treatment in individuals after exposure to aerosolized pathogens, where the goal of immediate treatment would be to rapidly reduce bacterial dose from a lethal to a nonlethal or subclinical level," says Montelaro.


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. Study quantifies the size of holes antibacterials create in cell walls to kill bacteria
2. Antibacterial agent used in common soaps found in increasing amounts in freshwater lakes
3. Antibacterial proteins molecular workings revealed
4. Genetic survey of endangered Antarctic blue whales shows surprising diversity
5. University of Houston study shows BP oil spill hurt marshes, but recovery possible
6. Weakness can be an advantage in surviving deadly parasites, a new study shows
7. Study shows unified process of evolution in bacteria and sexual eukaryotes
8. Sexual reproduction brings long-term benefits, study shows
9. UCSB study shows forest insects and diseases arrive in US via imported plants
10. Study shows botanical formula fights prostate cancer
11. Transcatheter aortic valve implantation shows promise in patients with severe aortic stenosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... research undertaken by Fit Small Business has revealed ... simply asked which office technology had they not used in ... Insights on what will be key features in ... industry leaders including Penelope Trunk , Martin Lindstrom ... Some of these findings included; ...
(Date:1/6/2017)... 2017  SomaLogic announced today that it has ... by iCarbonX, the China -based ... Digital Health Ecosystem that can define each person,s ... biological, behavioral and psychological data, the Internet and ... SomaLogic will provide proteomics data and applications expertise ...
(Date:12/22/2016)... MOUNTAIN VIEW, Calif. , Dec. 20, 2016  As ... all levels, 23andMe, the leading personal genetics company, recently released ... Only Me . The book focuses on the topics ... the Next Generation Science Standards (NGSS) taught in elementary school ... the second in a series by illustrator Ariana Killoran ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... DIEGO , Jan. 17, 2017  An ... School of Medicine and St. Boniface Hospital Albrechtsen ... for peripheral neuropathy, an unmet health need affecting ... the Journal of Clinical Investigation, their results identify ... that prevent and reverse neuronal injury in animal ...
(Date:1/17/2017)... DUBLIN , Jan. 17, 2017 ... new report "Molecular Diagnostics - Technologies, Markets and Companies" ... ... molecular diagnostics has increased remarkably during the past few years. ... in developing molecular diagnostics and 342 of these are profiled ...
(Date:1/17/2017)... ... January 17, 2017 , ... One Million Solutions in ... $3 million in investment towards 15+ TEC Validation Projects™. As a pre-competitive consortium, ... applicability in drug safety assessment, for the industry as a whole. , Through ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... precedential publication its decision on the appeal filed by India-based Dishman Pharmaceutical & ... of contract against DPCL and one of its Dishman Group’s 100% wholly owned ...
Breaking Biology Technology: